Mazdutide vs Survodutide: price and facts compared (2026)
Neither product has an in-stock offer right now.
| Mazdutide | Survodutide | |
|---|---|---|
| Category | GLP-1 | GLP-1 |
| Standard size | 10mg | 10mg |
| All sizes | 5mg, 10mg | 5mg, 10mg |
| Cheapest now | Not in stock | Not in stock |
| Price per mg | Priced as a set | Priced as a set |
| Vendors | 0 | 0 |
| Forms | Vial | Vial |
| Regulatory status | Investigational · phase 3 in China (Innovent / Eli Lilly). Not approved for human use. | Investigational · phase 3 (Boehringer Ingelheim / Zealand). Not approved for human use. |
| Stock | Out of stock | Out of stock |
Mazdutide is an investigational dual GLP-1 and glucagon receptor agonist developed by Innovent and Eli Lilly, in phase 3 obesity trials in China. Research vendors sell it lyophilized in 5 mg and 10 mg vials.
Mazdutide prices →Survodutide (BI 456906) is an investigational dual glucagon and GLP-1 receptor agonist developed by Boehringer Ingelheim and Zealand Pharma, in phase 3 obesity trials. It is sold lyophilized in 5 mg and 10 mg vials for research.
Survodutide prices →Questions
Prices are read from each vendor's product page weekly, converted to the price after any listed code, and shown before shipping. Stock status is captured at the same time. Rankings are by price only. PeptideTech earns a commission when you buy through a link; it never changes the order.
Full method →